Presentation is loading. Please wait.

Presentation is loading. Please wait.

Randomized controlled trial of biofilm antimicrobial susceptibility testing in cystic fibrosis patients  Yvonne C.W. Yau, Felix Ratjen, Elizabeth Tullis,

Published byPeter Alban Montgomery Modified over 6 years ago

Similar presentations

Presentation on theme: "Randomized controlled trial of biofilm antimicrobial susceptibility testing in cystic fibrosis patients  Yvonne C.W. Yau, Felix Ratjen, Elizabeth Tullis,"— Presentation transcript:

1 Randomized controlled trial of biofilm antimicrobial susceptibility testing in cystic fibrosis patients  Yvonne C.W. Yau, Felix Ratjen, Elizabeth Tullis, Pearce Wilcox, Andreas Freitag, Mark Chilvers, Hartmut Grasemann, James Zlosnik, David Speert, Mary Corey, Sanja Stanojevic, Larissa Matukas, Timothy Ronan Leahy, Sarah Shih, Valerie Waters  Journal of Cystic Fibrosis  Volume 14, Issue 2, Pages (March 2015) DOI: /j.jcf Copyright © 2014 European Cystic Fibrosis Society. Terms and Conditions

2 Fig. 1 CONSORT flow chart. Selection of study population and drop outs. N=number of patients; n=number of exacerbations. PA: Pseudomonas aeruginosa. Journal of Cystic Fibrosis  , DOI: ( /j.jcf ) Copyright © 2014 European Cystic Fibrosis Society. Terms and Conditions

3 Fig. 2 Mean change in sputum Pseudomonas aeruginosa density (log10colonyformingunits (CFU)/ml) from day 0 to day 14 of antibiotic treatment and to the 1month follow-up visit (±standard error of the mean) for all 74 pulmonary exacerbations. Conventional group: open circle, biofilm group: closed square. Journal of Cystic Fibrosis  , DOI: ( /j.jcf ) Copyright © 2014 European Cystic Fibrosis Society. Terms and Conditions

4 Fig. 3 Mean change in A) forced expiratory volume in 1s (FEV1) (L) and B) forced vital capacity (FVC) (L) from day 0 to day 7, 14 of antibiotic treatment and to the 1month follow-up visit (±standard error of the mean) for all 74 pulmonary exacerbations. Conventional group: open circle, biofilm group: closed square. Journal of Cystic Fibrosis  , DOI: ( /j.jcf ) Copyright © 2014 European Cystic Fibrosis Society. Terms and Conditions

Download ppt "Randomized controlled trial of biofilm antimicrobial susceptibility testing in cystic fibrosis patients  Yvonne C.W. Yau, Felix Ratjen, Elizabeth Tullis,"

Similar presentations

Cheryl Cameron, Mark W. Lodes, William M. Gershan 

Cheryl Cameron, Mark W. Lodes, William M. Gershan 
Effect of dornase alfa on inflammation and lung function: Potential role in the early treatment of cystic fibrosis  Michael W. Konstan, Felix Ratjen 

Effect of dornase alfa on inflammation and lung function: Potential role in the early treatment of cystic fibrosis  Michael W. Konstan, Felix Ratjen 
Multiple reaction monitoring mass spectrometry to identify novel plasma protein biomarkers of treatment response in cystic fibrosis pulmonary exacerbations 

Multiple reaction monitoring mass spectrometry to identify novel plasma protein biomarkers of treatment response in cystic fibrosis pulmonary exacerbations 
A phase 3, multi-center, multinational, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of levofloxacin inhalation.

A phase 3, multi-center, multinational, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of levofloxacin inhalation.
Dietary supplementation with multiple micronutrients: No beneficial effects in pediatric cystic fibrosis patients  Johanna H. Oudshoorn, Peter H.C. Klijn,

Dietary supplementation with multiple micronutrients: No beneficial effects in pediatric cystic fibrosis patients  Johanna H. Oudshoorn, Peter H.C. Klijn,
William G. Flight, Jonathan Shaw, Susan Johnson, A

William G. Flight, Jonathan Shaw, Susan Johnson, A
Felix Ratjen, Paul Koker, David E

Felix Ratjen, Paul Koker, David E
How does heart rate recovery after sub-maximal exercise correlate with maximal exercise testing in children with CF?  Sarah P. Cohen, David M. Orenstein 

How does heart rate recovery after sub-maximal exercise correlate with maximal exercise testing in children with CF?  Sarah P. Cohen, David M. Orenstein 
H. Grasemann, E. Tullis, F. Ratjen  Journal of Cystic Fibrosis 

H. Grasemann, E. Tullis, F. Ratjen  Journal of Cystic Fibrosis 
Avani C. Modi, Crystal S. Lim, Nami Yu, David Geller, Mary H

Avani C. Modi, Crystal S. Lim, Nami Yu, David Geller, Mary H
A randomized double blind, placebo controlled phase 2 trial of BIIL 284 BS (an LTB4 receptor antagonist) for the treatment of lung disease in children.

A randomized double blind, placebo controlled phase 2 trial of BIIL 284 BS (an LTB4 receptor antagonist) for the treatment of lung disease in children.
Patrick A. Flume, John P. Clancy, George Z. Retsch-Bogart, D

Patrick A. Flume, John P. Clancy, George Z. Retsch-Bogart, D
Measures of body habitus are associated with lung function in adults with cystic fibrosis: A population-based study  Doug L. Forrester, Alan J. Knox,

Measures of body habitus are associated with lung function in adults with cystic fibrosis: A population-based study  Doug L. Forrester, Alan J. Knox,
D. Worlitzsch, C. Rintelen, K. Böhm, B. Wollschläger, N. Merkel, M

D. Worlitzsch, C. Rintelen, K. Böhm, B. Wollschläger, N. Merkel, M
A longitudinal analysis of chronic MRSA and Pseudomonas aeruginosa co-infection in cystic fibrosis: A single-center study  Maret L. Maliniak, Arlene A.

A longitudinal analysis of chronic MRSA and Pseudomonas aeruginosa co-infection in cystic fibrosis: A single-center study  Maret L. Maliniak, Arlene A.
The ease of breathing test tracks clinical changes in cystic fibrosis

The ease of breathing test tracks clinical changes in cystic fibrosis
Impact of antibiotic treatment for pulmonary exacerbations on bacterial diversity in cystic fibrosis  T.W.V. Daniels, G.B. Rogers, F.A. Stressmann, C.J.

Impact of antibiotic treatment for pulmonary exacerbations on bacterial diversity in cystic fibrosis  T.W.V. Daniels, G.B. Rogers, F.A. Stressmann, C.J.
Increased serum concentration of G-CSF in cystic fibrosis patients with chronic Pseudomonas aeruginosa pneumonia  P.Ø. Jensen, C. Moser, A. Kharazmi,

Increased serum concentration of G-CSF in cystic fibrosis patients with chronic Pseudomonas aeruginosa pneumonia  P.Ø. Jensen, C. Moser, A. Kharazmi,
Pulmonary exacerbations in CF patients with early lung disease

Pulmonary exacerbations in CF patients with early lung disease
Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study  Christine Rønne.

Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study  Christine Rønne.

Similar presentations

Ads by Google